메뉴 건너뛰기




Volumn 4, Issue 3, 2014, Pages

Acute Exacerbation and Respiratory InfectionS in COPD (AERIS): Protocol for a prospective, observational cohort study

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; STEROID;

EID: 84897523951     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-004546     Document Type: Article
Times cited : (10)

References (44)
  • 1
    • 84859424158 scopus 로고    scopus 로고
    • Chronic obstructive pulmonary disease
    • Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012;379:1341-51.
    • (2012) Lancet , vol.379 , pp. 1341-1351
    • Decramer, M.1    Janssens, W.2    Miravitlles, M.3
  • 2
    • 78349233159 scopus 로고    scopus 로고
    • Prioritized research agenda for prevention and control of chronic respiratory diseases
    • Bousquet J, Kiley J, Bateman ED, et al. Prioritized research agenda for prevention and control of chronic respiratory diseases. Eur Respir J 2010;36:995-1001.
    • (2010) Eur Respir J , vol.36 , pp. 995-1001
    • Bousquet, J.1    Kiley, J.2    Bateman, E.D.3
  • 3
    • 84871036375 scopus 로고    scopus 로고
    • Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systemic analysis for the Global Burden of Disease Study 2010
    • Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systemic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-128.
    • (2012) Lancet , vol.380 , pp. 2095-2128
    • Lozano, R.1    Naghavi, M.2    Foreman, K.3
  • 4
    • 84871051576 scopus 로고    scopus 로고
    • Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systemic analysis for the Global Burden of Disease Study 2010
    • Vos T, Flaxman AD, Lozano R, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systemic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163-96.
    • (2012) Lancet , vol.380 , pp. 2163-2196
    • Vos, T.1    Flaxman, A.D.2    Lozano, R.3
  • 5
    • 84871099014 scopus 로고    scopus 로고
    • Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systemic analysis for the Global Burden of Disease Study 2010
    • Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systemic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2197-223.
    • (2012) Lancet , vol.380 , pp. 2197-2223
    • Murray, C.J.1    Vos, T.2    Lozano, R.3
  • 7
    • 56749157688 scopus 로고    scopus 로고
    • Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations
    • Seemungal TA, Wilkinson TM, Hurst JR, et al. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med 2008;178:1139-47.
    • (2008) Am J Respir Crit Care Med , vol.178 , pp. 1139-1147
    • Seemungal, T.A.1    Wilkinson, T.M.2    Hurst, J.R.3
  • 8
    • 0036794862 scopus 로고    scopus 로고
    • Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
    • DOI 10.1136/thorax.57.10.847
    • Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847-52. (Pubitemid 35178607)
    • (2002) Thorax , vol.57 , Issue.10 , pp. 847-852
    • Donaldson, G.C.1    Seemungal, T.A.R.2    Bhowmik, A.3    Wedzicha, J.A.4
  • 10
    • 27744556967 scopus 로고    scopus 로고
    • Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
    • DOI 10.1136/thx.2005.040527
    • Soler-Cataluña JJ, Martínez-García MA, Román-Sánchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005;60:925-31. (Pubitemid 41598207)
    • (2005) Thorax , vol.60 , Issue.11 , pp. 925-931
    • Soler-Cataluna, J.J.1    Martinez-Garcia, M.A.2    Roman, S.P.3    Salcedo, E.4    Navarro, M.5    Ochando, R.6
  • 11
    • 68849131951 scopus 로고    scopus 로고
    • Effect of exacerbations on health status in subjects with chronic obstructive pulmonary disease
    • Nishimura K, Sato S, Tsukino M, et al. Effect of exacerbations on health status in subjects with chronic obstructive pulmonary disease. Health Qual Life Outcomes 2009;7:69.
    • (2009) Health Qual Life Outcomes , vol.7 , pp. 69
    • Nishimura, K.1    Sato, S.2    Tsukino, M.3
  • 12
    • 0033998254 scopus 로고    scopus 로고
    • The economic burden of COPD
    • Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000;117(2 Suppl):5S-9S. (Pubitemid 30111556)
    • (2000) Chest , vol.117 , Issue.2 SUPPL.
    • Sullivan, S.D.1    Ramsey, S.D.2    Lee, T.A.3
  • 13
    • 77956689733 scopus 로고    scopus 로고
    • Susceptibility to exacerbation in chronic obstructive pulmonary disease
    • Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-38.
    • (2010) N Engl J Med , vol.363 , pp. 1128-1138
    • Hurst, J.R.1    Vestbo, J.2    Anzueto, A.3
  • 15
    • 57149105188 scopus 로고    scopus 로고
    • Infection in the pathogenesis and course of chronic obstructive pulmonary disease
    • Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008;359:2355-65.
    • (2008) N Engl J Med , vol.359 , pp. 2355-2365
    • Sethi, S.1    Murphy, T.F.2
  • 16
    • 77649119443 scopus 로고    scopus 로고
    • Disordered microbial communities in asthmatic airways
    • Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PLoS ONE 2010;5:e8578.
    • (2010) PLoS ONE , vol.5
    • Hilty, M.1    Burke, C.2    Pedro, H.3
  • 17
    • 77049098120 scopus 로고    scopus 로고
    • A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations
    • Huang YJ, Kim E, Cox MJ, et al. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS 2010;14:9-59.
    • (2010) OMICS , vol.14 , pp. 9-59
    • Huang, Y.J.1    Kim, E.2    Cox, M.J.3
  • 18
    • 79952063902 scopus 로고    scopus 로고
    • Analysis of the lung microbiome in the "healthy" smoker and in COPD
    • Erb-Downward JR, Thompson DL, Han MK, et al. Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS ONE 2011;6:e16384.
    • (2011) PLoS ONE , vol.6
    • Erb-Downward, J.R.1    Thompson, D.L.2    Han, M.K.3
  • 19
    • 84869239734 scopus 로고    scopus 로고
    • Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD
    • Garcha DS, Thurston SJ, Patel AR, et al. Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD. Thorax 2012;67:1075-80.
    • (2012) Thorax , vol.67 , pp. 1075-1080
    • Garcha, D.S.1    Thurston, S.J.2    Patel, A.R.3
  • 20
    • 84867427320 scopus 로고    scopus 로고
    • The lung microbiome in moderate and severe chronic obstructive pulmonary disease
    • Pragman AA, Kim HB, Reilly CS, et al. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS ONE 2012;7:e47305.
    • (2012) PLoS ONE , vol.7
    • Pragman, A.A.1    Kim, H.B.2    Reilly, C.S.3
  • 21
    • 0037103420 scopus 로고    scopus 로고
    • New strains of bacteria and exacerbations of chronic obstructive pulmonary disease
    • DOI 10.1056/NEJMoa012561
    • Sethi S, Evans N, Grant BJ, et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;347:465-71. (Pubitemid 34879333)
    • (2002) New England Journal of Medicine , vol.347 , Issue.7 , pp. 465-471
    • Sethi, S.1    Evans, N.2    Grant, B.J.B.3    Murphy, T.F.4
  • 23
    • 0036727140 scopus 로고    scopus 로고
    • Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations
    • DOI 10.1136/thorax.57.9.759
    • Patel IS, Seemungal TA, Wilks M, et al. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002;57:759-64. (Pubitemid 34984972)
    • (2002) Thorax , vol.57 , Issue.9 , pp. 759-764
    • Patel, I.S.1    Seemungal, T.A.R.2    Wilks, M.3    Lloyd-Owen, S.J.4    Donaldson, G.C.5    Wedzicha, J.A.6
  • 25
    • 84859334307 scopus 로고    scopus 로고
    • Effect of bronchial colonisation on airway and systemic inflammation in stable COPD
    • Marin A, Garcia-Aymerich J, Sauleda J, et al. Effect of bronchial colonisation on airway and systemic inflammation in stable COPD. COPD 2012;9:121-30.
    • (2012) COPD , vol.9 , pp. 121-130
    • Marin, A.1    Garcia-Aymerich, J.2    Sauleda, J.3
  • 27
    • 34147214922 scopus 로고    scopus 로고
    • (revised 2011). (accessed 12 Feb 2014)
    • Global Initiative for Chronic Obstructive Lung Disease, Inc. Global strategy for the diagnosis, management, and prevention of COPD (revised 2011). http://www.goldcopd.org/uploads/users/files/GOLD-Report-2011-Feb21.pdf (accessed 12 Feb 2014).
    • Global Strategy for the Diagnosis, Management, and Prevention of COPD
  • 28
    • 0023164742 scopus 로고
    • Antiobiotic therapy in exacerbations of chronic obstructive pulmonary disease
    • Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204. (Pubitemid 17009877)
    • (1987) Annals of Internal Medicine , vol.106 , Issue.2 , pp. 196-204
    • Anthonisen, N.R.1    Manfreda, J.2    Warren, C.P.W.3
  • 30
    • 84897525707 scopus 로고    scopus 로고
    • accessed 12 Feb 2014
    • BAPEN. The MUST toolkit. http://www.bapen.org.uk/screening-for- malnutrition/must/must-toolkit/the-must-itself (accessed 12 Feb 2014).
    • The MUST Toolkit
  • 31
    • 79960186020 scopus 로고    scopus 로고
    • Properties of the COPD assessment test in a cross-sectional European study
    • Jones PW, Brusselle G, Dal Negro RW, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J 2011;38:29-35.
    • (2011) Eur Respir J , vol.38 , pp. 29-35
    • Jones, P.W.1    Brusselle, G.2    Dal Negro, R.W.3
  • 32
    • 84976980617 scopus 로고
    • An extended activities of daily living scale for stroke patients
    • Nouri FM, Lincoln NB. An extended activities of daily living scale for stroke patients. Clin Rehabil 1987;1:301-5.
    • (1987) Clin Rehabil , vol.1 , pp. 301-305
    • Nouri, F.M.1    Lincoln, N.B.2
  • 34
    • 0025688231 scopus 로고
    • EuroQol - A new facility for the measurement of health-related quality of life
    • The EuroQol Group
    • The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
    • (1990) Health Policy , vol.16 , pp. 199-208
  • 36
    • 69349097681 scopus 로고    scopus 로고
    • An introduction to conducting COPD exacerbation research
    • Hurst JR, Wedzicha JA. An introduction to conducting COPD exacerbation research. Respir Med 2009;5:38-44.
    • (2009) Respir Med , vol.5 , pp. 38-44
    • Hurst, J.R.1    Wedzicha, J.A.2
  • 37
    • 42949146028 scopus 로고    scopus 로고
    • Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE)
    • Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J 2008;31:869-73.
    • (2008) Eur Respir J , vol.31 , pp. 869-873
    • Vestbo, J.1    Anderson, W.2    Coxson, H.O.3
  • 38
    • 77949363490 scopus 로고    scopus 로고
    • Genetic epidemiology of COPD (COPDGene) study design
    • Regan EA, Hokanson JE, Murphy JR, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD 2010;7:32-43.
    • (2010) COPD , vol.7 , pp. 32-43
    • Regan, E.A.1    Hokanson, J.E.2    Murphy, J.R.3
  • 39
    • 80051708982 scopus 로고    scopus 로고
    • Novel outcomes and end points: Biomarkers in chronic obstructive pulmonary disease clinical trials
    • Woodruff PG. Novel outcomes and end points: biomarkers in chronic obstructive pulmonary disease clinical trials. Proc Am Thorac Soc 2011;8:350-5.
    • (2011) Proc Am Thorac Soc , vol.8 , pp. 350-355
    • Woodruff, P.G.1
  • 41
    • 84863824244 scopus 로고    scopus 로고
    • COPD exacerbations: Causes, prevention, and treatment
    • Mackay AJ, Hurst JR. COPD exacerbations: causes, prevention, and treatment. Med Clin North Am 2012;96:789-809.
    • (2012) Med Clin North Am , vol.96 , pp. 789-809
    • Mackay, A.J.1    Hurst, J.R.2
  • 42
    • 34147214922 scopus 로고    scopus 로고
    • updated accessed 12 Feb 2014
    • Global Initiative for Chronic Obstructive Lung Disease, Inc. Global strategy for the diagnosis, management, and prevention of COPD (updated 2013). http://www.goldcopd.org/uploads/users/files/GOLD-Report-2013-Feb20.pdf (accessed 12 Feb 2014).
    • (2013) Global Strategy for the Diagnosis, Management, and Prevention of COPD
  • 43
    • 77952490797 scopus 로고    scopus 로고
    • Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: A randomized controlled trial
    • Sethi S, Jones PW, Theron MS, et al. Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Respir Res 2010;11:10.
    • (2010) Respir Res , vol.11 , pp. 10
    • Sethi, S.1    Jones, P.W.2    Theron, M.S.3
  • 44
    • 80052157895 scopus 로고    scopus 로고
    • Azithromycin for prevention of exacerbations of COPD
    • Albert RK, Connett J, Bailey WC, et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med 2011;365:689-98.
    • (2011) N Engl J Med , vol.365 , pp. 689-698
    • Albert, R.K.1    Connett, J.2    Bailey, W.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.